Pharmacokinetic Properties of Intravenous Ibuprofen in Healthy Chinese Volunteers

被引:5
|
作者
Shen, Yali [1 ]
Nan, Feng [2 ]
Li, Mei [2 ]
Liang, Maozhi [2 ]
Wang, Ying [2 ]
Chen, Zhihui [2 ]
Luo, Zhu [2 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Abdominal Oncol, Ctr Canc, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Hosp, GCP Ctr, Inst Drug Clin Trials, Chengdu 610041, Peoples R China
关键词
PLACEBO-CONTROLLED TRIAL; SHORTENED INFUSION TIME; IV-IBUPROFEN; DOUBLE-BLIND; POSTOPERATIVE PAIN; SURVEILLANCE TRIAL; DRUG ACCUMULATION; EVALUATE SAFETY; OPEN-LABEL; MULTICENTER;
D O I
10.1007/s40261-016-0453-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
No pharmacokinetic data of intravenous ibuprofen were available in a Chinese population and the published information remained inadequate. The present study aimed to investigate the pharmacokinetic properties of intravenous ibuprofen in healthy Chinese volunteers after single- and multiple-dose administration. Twelve subjects received single doses of 200, 400, and 800 mg intravenous ibuprofen, respectively, and multiple doses of 400 mg intravenous ibuprofen, four times per day (every 6 h) till the morning of the sixth day in each study period. After single doses of 200, 400 and 800 mg and multiple doses of 400 mg intravenous ibuprofen, the main pharmacokinetic parameters obtained were: maximum plasma concentration (C (max)) 23.05 +/- 2.96, 41.90 +/- 3.22, 76.06 +/- 8.70, and 49.53 +/- 3.92 mu g/ml, respectively, which were achieved immediately at the end of the infusion; area under the plasma concentration-time curve from time zero to the time of last quantifiable concentration (AUC(0-t) ) 49.82 +/- 10.92, 88.79 +/- 12.43, 152.34 +/- 25.23, and 106.68 +/- 18.94 A mu g center dot h/mL, respectively; AUC from time zero to infinity (AUC(0-a)) 51.91 +/- 10.67, 91.46 +/- 12.06, 155.04 +/- 25.70, and 108.58 +/- 19.49 A mu g center dot h/ml, respectively; half-life (t (A1/2)) 1.87 +/- 0.30, 1.93 +/- 0.24, 2.02 +/- 0.38, and 1.74 +/- 0.26 h, respectively. The accumulation index (AI) was 1.22 +/- 0.17 after multiple doses. The most obvious accumulation was observed in males; other parameters revealed no significant differences. Similar pharmacokinetic properties of intravenous ibuprofen in healthy Chinese volunteers were observed to those reported in a Caucasian population. Multiple doses of intravenous ibuprofen every 6 h caused slight accumulation. Except for the AI, sex did not affect the pharmacokinetics of intravenous ibuprofen. ChiCTR-IIR-15007347.
引用
收藏
页码:1051 / 1058
页数:8
相关论文
共 50 条
  • [21] Pharmacokinetic differences between the epimers of cefotetan disodium after single intravenous injection in healthy Chinese volunteers
    Meng-xiang Su
    Min-hong Liu
    Bin Di
    Li-li Huang
    Yuan Jiang
    Peng-cheng Ma
    Tai-jun Hang
    European Journal of Drug Metabolism and Pharmacokinetics, 2011, 36 : 223 - 228
  • [22] A Pharmacokinetic Study of an Ibuprofen Topical Patch in Healthy Male and Female Adult Volunteers
    Lewis, Fraser
    Connolly, Mark P.
    Bhatt, Aomesh
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (07): : 684 - 691
  • [23] Pharmacokinetic Properties of S-oxiracetam After Single and Multiple Intravenous Infusions in Healthy Volunteers
    Dahu Liang
    Jie Shen
    Yuanwei Jia
    Min Dai
    Xianghong Li
    Lixiang Zhou
    Weijia Wang
    Bin Yang
    Jing Shao
    Yan Jiang
    Haitang Xie
    Hua Sun
    European Journal of Drug Metabolism and Pharmacokinetics, 2021, 46 : 793 - 805
  • [24] Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers
    Hoover, Randall
    Hunt, Thomas
    Benedict, Michael
    Paulson, Susan K.
    Lawrence, Laura
    Cammarata, Sue
    Sun, Eugene
    CLINICAL THERAPEUTICS, 2016, 38 (01) : 53 - 65
  • [25] Pharmacokinetic Properties of S-oxiracetam After Single and Multiple Intravenous Infusions in Healthy Volunteers
    Liang, Dahu
    Shen, Jie
    Jia, Yuanwei
    Dai, Min
    Li, Xianghong
    Zhou, Lixiang
    Wang, Weijia
    Yang, Bin
    Shao, Jing
    Jiang, Yan
    Xie, Haitang
    Sun, Hua
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2021, 46 (06) : 793 - 805
  • [26] Bioequivalence and Pharmacokinetic Evaluation of Regorafenib Tablets in Healthy Chinese Volunteers
    Wang, Zhaoyu
    Zhang, Yun
    Liu, Jingjing
    Chen, Xijing
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (12): : 1317 - 1323
  • [27] PHARMACOKINETIC STUDIES OF CONVENTIONAL IBUPROFEN AND MULTIUNIT DOSAGE FORMULATION OF SUSTAINED-RELEASE IBUPROFEN IN HEALTHY-VOLUNTEERS
    TIPNIS, HP
    SHINGTE, MV
    GANDHI, IS
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1990, 48 (02): : 282 - 289
  • [28] Population pharmacokinetic/pharmacodynamic modelling of nifekalant in healthy Chinese volunteers
    Zhang, Jiashan
    Zan, Ying
    Huo, Hua
    Liu, Yanfang
    Tang, Yunbiao
    Han, Yaling
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 151
  • [29] Pharmacokinetic, pharmacodynamic, and safety study of intravenous ganaxolone in healthy adult volunteers
    Barra, M.
    Vaitkevicius, H.
    Husain, A.
    Raja, S.
    MacLeod, D.
    Guptill, J.
    Hulihan, J.
    Gasior, M.
    Rybak, E.
    EPILEPSIA, 2023, 64 : 178 - 179
  • [30] PHARMACOKINETIC INTERACTION BETWEEN INTRAVENOUS PHENYTOIN AND AMIODARONE IN HEALTHY-VOLUNTEERS
    NOLAN, PE
    MARCUS, FI
    HOYER, GL
    BLISS, M
    GEAR, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (01) : 43 - 50